FDA panel backs highly controversial ALS drug in rare 2nd review
WASHINGTON (AP) — A panel of federal well being advisers voted Wednesday to advocate approval of an experimental drug to deal with Lou Gehrig’s illness, a exceptional turnaround for the extremely controversial drug which was beforehand rejected by the identical group earlier this yr. Meals and Drug Administration advisers voted 7 to 2 that Amylyx … Read more